Mario Berkowitz

Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial

Sunil Bhandari, Philip A. Kalra, Mario Berkowitz et al. · Nephrology Dialysis Transplantation · 2020 · 95 citations · Full text

Correlation of radiographic and arthroscopic findings with rotator cuff tears and degenerative joint disease

Hilary Umans, Helene Pavlov, Mario Berkowitz et al. · Journal of Shoulder and Elbow Surgery · 2001 · 33 citations

Rheumatology, Rotator Cuff Tears, Degenerative Joint Disease +9

MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study

Mark C. Genovese, Mario Berkowitz, Philip G. Conaghan et al. · The Lancet Rheumatology · 2020 · 27 citations

Inflammation, Rheumatology, Rheumatoid Disorder +13

Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial

Georg Schett, Mario Berkowitz, Katherine Davy et al. · The Lancet Rheumatology · 2020 · 20 citations

Inflammation, Rheumatology, Autoimmune Disease +11

Arthroscopic acromioclavicular resection

Mario Berkowitz, Russell F. Warren, David W. Altchek et al. · Operative Techniques in Sports Medicine · 1997 · 10 citations

Thoracic Surgery, Surgery, Joint Replacement +5